This Study Explores the Mental Health Impact of Two Akashic Records Sessions.

NCT07219914 | Active Not Recruiting

• 1 other identifier: #2024-0199
• Study Type: interventional
• Target: 117
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical study is to learn the impact of two Akashic Records sessions on mental health symptoms in adults. We want to see how sessions are linked to stress, anxiety, and depression, and to resilience (ability to bounce back) and feelings of connectedness (to self, community, and humanity). Main questions this study will answer are: After two sessions, what is the impact on stress, anxiety, and depression? After two sessions, what is the impact on resilience and connectedness? How do participants describe their experience of the sessions? After two sessions, what are participants' views of their problems (insight), emotional experiences (impact) and observable behaviors in their daily life? What participants will do: Complete online surveys about their mood at four points: before the first session, before the second session, after the second session, and again 2 months later. Surveys include: DASS-21 (Depression, Anxiety, and Stress Scale) CD-RISC-10 (Connor-Davidson Resilience Scale) WATTS (Connectedness Scale) A short demographic form and satisfaction survey Attend two individual Akashic Records sessions (50-90 minutes each) over private video platform with a licensed clinical social worker (principal investigator) The first 50 participants will also join a one-hour interview with open ended questions with a licensed clinical social worker (co-investigator) about one week after the second session to share their experience in their own words. Who can take part: Adults ages 18 and older who can read and consent in English and who have experienced stress, anxiety, or low mood in the past year. How the research will happen: Sessions are held by secure video call. Participants will also complete private online surveys before, during, and after the sessions. Some participants may be invited to share their experiences in a one-on-one interview. All information is kept private and names are removed before analysis. Risks and benefits: Talking about personal topics may bring up strong emotions. Licensed clinicians conduct sessions, offer support, and provide referrals if needed. Possible benefits include new insights, greater peace or meaning, and improved coping; benefits are not guaranteed. Why this matters: Many people seek spiritual or transpersonal support for emotional concerns. This pilot study will provide early evidence on whether Akashic Records sessions may be a helpful, low-risk option and will guide future research.

Conditions

Resilience; Connectedness; Depression; Anxiety; Stress

Keywords

mental health; anixety; depression; stress; resilience; connectedness; transpersonal psychology; spirituality; past lives; akashic records; akashic field; exploratory pilot study; altered states

Outcome Measures

Primary Outcomes (1)

• DASS-21 (Depression, Anxiety, Stress) Clinical Scale

  Change in participant self-reported depression, anxiety, and stress symptoms as measured by the DASS-21 (Depression, Anxiety, Stress Scale - 21 items). The DASS-21 has three subscales (Depression, Anxiety, Stress), each ranging from 0-42. Higher scores indicate greater symptom severity. Scores are calculated by summing responses (0 = "did not apply to me at all" to 3 = "applied very much/most of the time") and multiplying by two for comparability with the original 42-item scale. Analysis will compare baseline to post-intervention values across timepoints. The DASS-21 will be given to participants at 4 time points during the study.

  T0: Baseline and 7 days before 1st session (Session #1 is within 30 days of prescreen). T1: No more than 7 days before 2nd session (Session #2 is 10-21 days after 1st). T2: Within 7-14 days after 2nd session. T3: Within 60-80 days after 2nd session

Secondary Outcomes (2)

• CD-RISC-10 (Resilience) Clinical Scale

  T0: Baseline and 7 days before 1st session (Session #1 is within 30 days of prescreen). T1: No more than 7 days before 2nd session (Session #2 is 10-21 days after 1st). T2: Within 7-14 days after 2nd session. T3: Within 60-80 days after 2nd session

• WATTS Connectedness Scale

  T0: Baseline and 7 days before 1st session (Session #1 is within 30 days of prescreen). T1: No more than 7 days before 2nd session (Session #2 is 10-21 days after 1st). T2: Within 7-14 days after 2nd session. T3: Within 60-80 days after 2nd session

Other Outcomes (1)

• Participant Satisfaction Survey (Feasibility/Acceptability)

  T2 (7-14 days after the second session, prior to the semi-structured interview)

Study Arms (1)

Akashic Records Session Arm

EXPERIMENTAL

All participants receive two Akashic Records sessions: one 90-minute session and one 50-minute session, delivered virtually by a licensed clinician. Participants also complete validated clinical scales at baseline, post-session, and 60-day follow-up.

Behavioral: Akashic Records Session

Interventions

Akashic Records Session BEHAVIORAL

Participants will receive two individual Akashic Records sessions. The first session lasts 90 minutes and the second session lasts 50 minutes. Sessions are conducted virtually by a licensed clinician trained in Akashic channeling. Participants are encouraged to set intentions, receive channeled information, and reflect on insights

Also known as: Akashic Channeling, Akashic Reading, Akashic Field Channeling

Akashic Records Session Arm

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• years old and over
• Ability and willingness to provide written, informed consent in English prior to initiation of any study-related procedures and adhere to all study requirements
• Willingness to engage in discussion about past life patterns and emotions
• Self-report of anxiety, depressive or stress symptoms in the last 12 months

You may not qualify if:

• Inability to provide consent due to cognitive impairment, mental health disorders, or other conditions that impact their ability to understand the nature, risks, and benefits of the study.
• History of alcohol or substance use disorder within 12 months
• History of hypomania or psychotic episode within 12 months
• Prior history (lifetime diagnosis) of schizophrenia spectrum, or other psychotic disorders
• Experiencing any other serious mental or physical health issues that would impact their ability to engage in the research study
• Has either attempted suicide, has documented medical history of suicidal ideation, or been hospitalized due to suicide risk within 1 year prior to prescreening.
• Previous Akashic Record Session with Interventionist, Candice S. Rasa, LCSW or previous Akashic Record Session with any other provider within 6 months.
• Any form of medicinal therapy should be stable 3 months prior to screening with no plan to start, stop or alter the use of any prescribed medications, supplements or other therapies from informed consent
• Any form of non-medical therapy should be stable 3 months prior to pre-screening with no plan to start, stop or alter use of psychotherapy, acupuncture, hypnosis, or other similar therapy from the time of providing informed consent.

Sponsors & Collaborators

• Rasa Healing Inc: lead

Study Sites (1)

Virtual/ No Physical Facility

Palm City, Florida, 34990, United States

Location

Related Publications (7)

• Sheldrake R. An experimental test of the hypothesis of formative causation. Riv Biol. 1992;85(3-4):431-43.

  PMID: 1341836 BACKGROUND

• Laszlo, E. (2007). Science and the Akashic Field: An Integral Theory of Everything. Inner Traditions.

  BACKGROUND

• Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008 Apr;31(2):180-91. doi: 10.1002/nur.20247.

  PMID: 18183564 BACKGROUND

• Watts, R., et al. (2017). Patients' accounts of increased "connectedness" and "acceptance" after psilocybin for treatment-resistant depression. Journal of Humanistic Psychology, 57(5), 520-564. https://doi.org/10.1177/0022167817709585

  BACKGROUND

• Rubik B, Muehsam D, Hammerschlag R, Jain S. Biofield Science and Healing: History, Terminology, and Concepts. Glob Adv Health Med. 2015 Nov;4(Suppl):8-14. doi: 10.7453/gahmj.2015.038.suppl. Epub 2015 Nov 1.

  PMID: 26665037 BACKGROUND

• Brysbaert M. How Many Participants Do We Have to Include in Properly Powered Experiments? A Tutorial of Power Analysis with Reference Tables. J Cogn. 2019 Jul 19;2(1):16. doi: 10.5334/joc.72.

  PMID: 31517234 BACKGROUND

• Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76-82. doi: 10.1002/da.10113.

  PMID: 12964174 BACKGROUND

MeSH Terms

Conditions

Depression; Anxiety Disorders; Psychological Well-Being

Condition Hierarchy (Ancestors)

Behavioral Symptoms; Behavior; Mental Disorders; Personal Satisfaction

Study Officials

• Candice S Rasa, LCSW

  Rasa Healing Inc

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Akashic Records Facilitator, Therapist

Model Details: Single-arm pilot study: all participants receive two Akashic Records sessions (one 90-minute and one 50-minute) and complete validated clinical scales at baseline, post-session, and 60-day follow-up

Study Record Dates

• First Submitted: October 18, 2025
• First Posted: October 22, 2025
• Study Start: June 21, 2024
• Primary Completion: November 22, 2025
• Study Completion: January 22, 2026
• Last Updated: October 24, 2025

Record last verified: 2025-10

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)